Asthma and COVID-19: do we finally have answers?

por Eger, Katrien, Bel, Elisabeth H.
Publicado 2021

Management of the patient with eosinophilic asthma: a new era begins

por de Groot, Jantina C., ten Brinke, Anneke, Bel, Elisabeth H.D.
Publicado 2015

Defining severe obstructive lung disease in the biologic era: an endotype-based approach

por Martin, Richard J., Bel, Elisabeth H., Pavord, Ian D., Price, David, Reddel, Helen K.
Publicado 2019

Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics

por Porsbjerg, Celeste M., Sverrild, Asger, Lloyd, Clare M., Menzies-Gow, Andrew N., Bel, Elisabeth H.
Publicado 2020

In vivo imaging of the airway wall in asthma: fibered confocal fluorescence microscopy in relation to histology and lung function

por Yick, Ching Yong, von der Thüsen, Jan H, Bel, Elisabeth H, Sterk, Peter J, Kunst, Peter W
Publicado 2011

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis

por Prazma, Charlene M., Bel, Elisabeth H., Price, Robert G., Bradford, Eric S., Albers, Frank C., Yancey, Steven W.
Publicado 2019

Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial

por van der Meer, Akke-Nynke, de Jong, Kim, Hoekstra-Kuik, Aranka, Bel, Elisabeth H., ten Brinke, Anneke
Publicado 2021

Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma

por Korn, Stephanie, Howarth, Peter, Smith, Steven G., Price, Robert G., Yancey, Steven W., Prazma, Charlene M., Bel, Elisabeth H.
Publicado 2022

“Take the active option” to support Healthy Lungs for Life

por Powell, Pippa, Troosters, Thierry, Franssen, Frits M.E., Spruit, Martijn A., Sealy, Steve, Bel, Elisabeth H., Smyth, Dan, Hiemstra, Pieter S.
Publicado 2015

The Impact of Allergic Rhinitis and Asthma on Human Nasal and Bronchial Epithelial Gene Expression

por Wagener, Ariane H., Zwinderman, Aeilko H., Luiten, Silvia, Fokkens, Wytske J., Bel, Elisabeth H., Sterk, Peter J., van Drunen, Cornelis M.
Publicado 2013

dsRNA-induced changes in gene expression profiles of primary nasal and bronchial epithelial cells from patients with asthma, rhinitis and controls

por Wagener, Ariane H, Zwinderman, Aeilko H, Luiten, Silvia, Fokkens, Wytske J, Bel, Elisabeth H, Sterk, Peter J, van Drunen, Cornelis M
Publicado 2014

IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial

por Crim, Courtney, Stone, Sally, Millar, Valerie, Lettis, Sally, Bel, Elisabeth H., Menzies-Gow, Andrew, Chanez, Pascal, Wenzel, Sally, Lugogo, Njira, Bleecker, Eugene R.
Publicado 2022

Response to mepolizumab treatment is sustained across 4-weekly dosing periods

por Pavord, Ian D., Bleecker, Eugene R., Buhl, Roland, Chanez, Pascal, Bel, Elisabeth H., Howarth, Peter, Bratton, Daniel J., Albers, Frank C., Yancey, Steven
Publicado 2020

Clinical profile of patients with adult-onset eosinophilic asthma

por de Groot, Jantina C., Storm, Huib, Amelink, Marijke, de Nijs, Selma B., Eichhorn, Edwin, Reitsma, Bennie H., Bel, Elisabeth H.D., ten Brinke, Anneke
Publicado 2016

Migration and allergic diseases: Findings from a population‐based study in adults in Amsterdam, the Netherlands

por Amoah, Abena S., Prins, Maria, Bel, Elisabeth H. D., Fokkens, Wytske J., Zwinderman, Aeilko H., Yazdanbakhsh, Maria, Maitland‐van der Zee, Anke H., van Ree, Ronald
Publicado 2022

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial

por Menzies-Gow, Andrew, Corren, Jonathan, Bel, Elisabeth H., Maspero, Jorge, Heaney, Liam G., Gurnell, Mark, Wessman, Peter, Martin, Ubaldo J., Siddiqui, Shahid, Garcia Gil, Esther
Publicado 2019

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions

por Gibson, Peter G., Prazma, Charlene M., Chupp, Geoffrey L., Bradford, Eric S., Forshag, Mark, Mallett, Stephen A., Yancey, Steve W., Smith, Steven G., Bel, Elisabeth H.
Publicado 2021

Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET

por Liu, Mark C., Bel, Elisabeth H., Kornmann, Oliver, Moore, Wendy C., Kaneko, Norihiro, Smith, Steven G., Martin, Neil, Price, Robert G., Yancey, Steven W., Humbert, Marc
Publicado 2022

SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma

por van Bragt, Job J.M.H., Hansen, Susanne, Djukanovic, Ratko, Bel, Elisabeth H.D., ten Brinke, Anneke, Wagers, Scott S., Maitland-van der Zee, Anke H., Porsbjerg, Celeste
Publicado 2021

Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma

por Kroes, Johannes A., Zielhuis, Sybrand W.J., De Jong, Kim, Hashimoto, Simone, Sont, Jacob K., Zielhuis, Sander W., Van Roon, Eric N., Bel, Elisabeth H., Ten Brinke, Anneke
Publicado 2022